| Dural contact | Prescribed dose (Gy/%isodose) | Volume of treatment (cc) | Primary tumor type | Delay surgery-RS (days) | Other relevant aspects |
---|---|---|---|---|---|---|
Patient #1 | No | 26Â Gy/50% | 3.5 | Kidney clear cell carcinoma | 28 | Â |
Patient #2 | No | 20 Gy/50% | 3.52 | Colorectal adenocarcinoma | 46 | RS tumor bed + 1 lesion |
Patient #3 | No | 20Â Gy/50% | 4.5 | NSCLC | 76 | Â |
Patient #4 | No | 22 Gy/50% | 0.8 | NSCLC | 139 | RS tumor bed + 2 lesions 2-piece surgery |